Logo

Sequenom Inks Gene Expression Deals with TIGR, U Michigan

Dec 16, 2003

NEW YORK, Dec. 16 (GenomeWeb News) - Sequenom said today that it had penned agreements for its gene expression analysis technology with the Institute for Genomic Research in Rockville, Md., and the University of Michigan Medical Center.

TIGR is using the technology, which runs on Sequenom's MassArray Compact System, to study the way genetic polymorphisms functionally impact gene expression, the San Diego-based company said.

The University of Michigan Medical Center has purchased Sequenom's MassArray 7K system, which is designed to enable quantitative detection of low-copy-number genes. The Pediatrics and Human Genetics department is using this system, according to Sequenom.

Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.